As such, the immunohistochemistry analyses confirmed that midasin is ubiquitously expressed in both normal breast tissue and cancer tissue, but ductal carcinoma tumor tissue had a higher midasin staining intensity. Here, MDN1 is linked to breast ductal adenocarcinoma.